AlphAIAlphAI — Financial news for AI agents
investing.comNOV 32 min read$CLVT

Why is Clarivate stock sliding today?

Clarivate (CLVT) stock fell 5.4% in pre-market trading after Q3 2026 results beat EPS estimates ($0.21 vs. $0.18) but missed revenue forecasts by 16.7% ($481.6M vs. $566.77M), down 9.2% YoY. Full-year revenue guidance ($1.96B-$1.98B) also fell short of consensus ($2.20B). The miss was exacerbated by portfolio disposals and cautious forward outlook.

Original reporting
investing.com
Published Nov 3, 2026, 12:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 1:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CLVT
Bearish
high confidence
Mentioned
$CLVT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CLVTBearishMed
01

Why it matters

The earnings miss and weak guidance suggest short‑term downside risk, but the divestiture may improve cash flow and focus.

02

Market read

The earnings release is the primary catalyst for the stock's pre‑market decline, offering a clear trading signal.

03

What to watch

Potential upside from organic growth in life‑sciences data services despite the recent segment sale.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Clarivate is a global intelligence provider that recently completed a $488.4 million divestiture of its Life Sciences & Healthcare segment.

Company-level read

Ticker impact

$CLVTBearishHigh confidence
Context

Clarivate reported Q3 2026 earnings with EPS beat but a 16.7% revenue miss and lowered full‑year guidance, causing a 5.4% pre‑market slide.

Expected impact

downward pressure as investors price in the revenue miss and reduced guidance

Evidence & confidence

The earnings release contains fresh, material numbers that missed consensus by a wide margin and guidance below expectations, which historically drives immediate price declines.

Market effects

Sector

Intelligence and data‑services sector may see broader scrutiny on revenue growth assumptions.

Regional

U.S. markets likely see modest drag from the stock's decline, but broader indices remain flat.

Global

Limited; impact confined to Clarivate and its immediate peers.

Counterpoint

What could challenge this read

If the divestiture improves margins long‑term, the stock could rebound after the initial sell‑off.

Key entities

  • company
    Clarivate

    Global intelligence provider reporting Q3 2026 results.

Read at source← All news

StoryClarivate reports Q3 loss as continuing revenue falls after LS&H divestiture

Also covered by

5 outlets

Related articles

NOV 3
$CLVTHighAI 8/10

Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation — Improved recurring organic revenue growth driven by portfolio transformation and AI-led innovation — — Updates 2026 financial outlook following the divestiture of Life Sciences & Healthcare

SEC EDGAR 8-K3 min
NOV 3
$CLVTHighAI 8/10

Clarivate shares fall 6% on revenue miss despite earnings beat

Clarivate (CLVT) reported Q3 earnings of $0.21 per share, beating estimates, but revenue of $481.6M missed expectations. Shares fell 6.63% premarket. Q4 guidance was mixed, with EPS matching estimates but revenue below. The company expects fiscal 2026 revenue of $1.97B, below consensus. Organic revenue grew 0.4% YoY, and adjusted EBITDA declined 1.8%.

investing.com2 min